Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP
Clinical trial NCT06125717 · COMPLETED
Trial details
- NCT number
- NCT06125717
- Sponsor
- Terrestrial Bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-02
- Primary completion
- 2023-03-13
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.